SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Sciences informs about update

27 Jan 2023 Evaluate

Solara Active Pharma Sciences has informed that the company (Solara) has successfully completed the inspection carried out by the World Health Organization (WHO) at its Cuddalore facility (Tamil Nadu) between January 23 – 26, 2023. The Cuddalore API site is a multi-product facility, caters wide range of APIs to various Regulated Markets across the globe, including U.S., Europe, Japan and other markets.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

603.95 22.65 (3.90%)
12-Jun-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1810.55
Dr. Reddys Lab 1273.70
Cipla 1391.50
Zydus Lifesciences 1108.90
Lupin 2286.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: